Subscribe To
Oric pharmaceuticals to present initial phase 1b clinical data for oric 114 in egfr/her2 exon 20 mutated nsclc at the european society of medical oncology (esmo) congress 2023
Company to host a conference call and webcast on Saturday, October 21, 2023, at 9:00 am ET featuring Dr. Alexander Spira to discuss initial data and p...
October 17, 2023, 4:30 pm
Gri bio announces partnership with the respiratory translational research collaboration to advance leading nkt regulation technology targeting earlier in the inflammatory cascade to modulate disease p
UK consortia brings together internationally recognized investigators in the UK’s leading centers of excellence to carry out experimental and early ...
October 17, 2023, 12:35 pm
Ocean biomedical (nasdaq: ocea) announces enrollment of patients for phase 1b study for chronic hepatitis b treatment in 50-50 joint venture with virion therapeutics
Providence, Rhode Island, Oct. 17, 2023 (GLOBE NEWSWIRE) — Ocean Biomedical, Inc. (NASDAQ: OCEA), a biopharma company working to accelerate the deve...
October 17, 2023, 12:01 pm
Evelo biosciences shares tank 46% after trial failure
Evelo Biosciences' shares have tumbled 46% in premarket trading after the biotech firm revealed disappointing results in a ...
October 17, 2023, 9:00 am
Sellas life sciences to present final data from phase 1/2 study of galinpepimut-s in combination with keytruda® (pembrolizumab) in patients with wt1+ platinum-resistant advanced ovarian cancer at the
NEW YORK, Oct. 17, 2023 (GLOBE NEWSWIRE) -- SELLAS Life Sciences Group, Inc. (NASDAQ: SLS) (“SELLAS'' or the “Company”), a late-stage clinical b...
October 17, 2023, 8:45 am
Fabled copper announces sampling of lithium-bearing pegmatite outcrops on quebec volt 1 project
Fabled Copper Corp. (CSE:FABL) announced that it has completed its First phase sampling program of thr...
October 17, 2023, 8:34 am
Tg therapeutics: things are stacking up against briumvi
TG Therapeutics, Inc. stock has declined by 75% since its approval highs, with little hope of recovery. The company's fortunes have been tied to its e...
October 16, 2023, 4:47 pm
Karuna therapeutics: karxt could become a new standard of care in schizophrenia
Karuna Therapeutics, Inc. stock had >8x gain after my Buy rating before successful phase 3 trial data f...
October 16, 2023, 2:41 pm
Roche's (rhhby) ms drug reduces brain lesions in phase ii study
Roche (RHHBY) presents new data from a phase II study, which shows that fenebrutinib is brain penetrant...
October 16, 2023, 2:17 pm
Prothena shares buoyed by sale rumors
Shares of Prothena Corporation (NASDAQ:PRTA) added almost 25% on rumours the biotechnology firm is exploring a sale ahead of the release of key data f...
October 16, 2023, 12:09 pm
Terns pharmaceuticals announces global phase 1 clinical trial design of tern-701 for the treatment of chronic myeloid leukemia
Investigational New Drug application cleared by U.S. Food and Drug Administration Design leverages insights from partner’s ongoing ...
October 16, 2023, 12:05 pm
Enphase energy launches iq8 microinverters for high-powered solar modules in india
FREMONT, Calif., Oct. 16, 2023 (GLOBE NEWSWIRE) — Enphase Energy, Inc. (NASDAQ: ENPH), a global energ...
October 16, 2023, 12:00 pm
: novo nordisk to buy hypertension treatment from for $1.3 billion from kbp biosciences
Novo Nordisk A/S NVODK:NOVO.B said Monday it will pay $1.3 billion to KBP Biosciences to buy ocedurenone for uncontrolled hypertension. Ocedurenone is...
October 16, 2023, 11:11 am
Clearside biomedical positive oasis and extension study data presented at the retina society 56th annual scientific meeting
– Excellent Safety Profile, Stable Vision, and Reduced Frequency of Injections Observed for up to 6 months – – ODYSSEY ...
October 16, 2023, 11:05 am
Olema oncology announces phase 2 monotherapy clinical results to be presented at the 2023 esmo congress
Oral presentation by Dr. Nancy U. Lin from Dana-Farber Cancer Institute at 8:55 a.m. CEST/2:55 a.m. ET on October 22, 2023Olema will host an investor ...
October 16, 2023, 11:02 am
Nanoviricides updates investors on phase 1a/1b trial of antiviral drug candidate for coronavirus
NanoViricides (NYSE-A:NNVC) said it has sufficient funds to complete its ongoing phase 1a/1b clinical t...
October 16, 2023, 9:13 am
Steppe gold starts to drawn down on its us$150mln financing package for ato expansion
Steppe Gold has drawn down US$9.6m from a US$150mln financing package that's in place to allow for the construction and development of ...
October 16, 2023, 8:54 am
Why is contrafect (cfrx) stock up 23% today?
ContraFect (NASDAQ: CFRX ) stock is rising higher on Monday as investors react to an update from the Food and Drug Administration (FDA). The FDA has ...
October 16, 2023, 8:19 am
Chf/jpy further potential up move reinforced by chf safe haven status
CHF was the top-performing currency among the USD pairs in the past five days. An uptick in geopolitical risk premium has reinforced CHF’s safe have...
October 16, 2023, 6:20 am
Chf/jpy further potential up move reinforced by chf safe haven status
CHF was the top-performing currency among the USD pairs in the past five days. An uptick in geopolitical risk premium has reinforced CHF’s safe have...
October 16, 2023, 5:29 am